Is Cocrystal Pharma, Inc. (COCP) a Buy, Sell, or Hold?
NASDAQ : COCP
Cocrystal Pharma, Inc. — Institutional Ownership
$1.08 USD
$0 (0.0%)
- Volume
- 0
- Average Volume
- 85.21K
- Market Capitalization
- $14.89M
- P/E Ratio
- -1.46
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $2.67
- Year Low
- $0.76
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.66
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-08-07 | Phillip Frost, M.D. | 2.78M | 13.90% |
| 2026-08-07 | FROST PHILLIP MD ET AL | 2.79M | 13.90% |
| 2026-08-07 | Frost Gamma Investments Trust | 2.71M | 13.60% |
| 2026-08-07 | Rubin Steven D | 2.72M | 14.10% |
| 2026-08-07 | OPKO HEALTH, INC. | 5.69M | 29.60% |
| 2026-08-07 | Frost Gamma Investments Trust | 2.71M | 13.50% |
| 2025-10-30 | Phillip Frost, M.D. | 2.46M | 17.80% |
| 2025-10-30 | Frost Gamma Investments Trust | 2.4M | 17.40% |
| 2025-10-02 | Frost Gamma Investments Trust | 1.32M | 10.10% |
| 2025-10-02 | Phillip Frost, M.D. | 1.38M | 10.60% |
| 2023-04-12 | Fred Hassan | 1.02M | 10.00% |
| 2022-02-10 | 13-3127734 | 1.9M | 1.95% |
| 2022-02-10 | 26-0385758 | 1.9M | 1.95% |
| 2021-05-17 | S | 6.52M | 6.69% |
| 2021-05-17 | S | 6.52M | 6.69% |
| 2021-05-17 | S | 6.52M | 6.69% |
| 2021-05-12 | 19188J300 | 9.74M | 9.00% |
| 2021-05-12 | 19188J300 | 9.74M | 9.00% |
| 2021-05-12 | 19188J300 | 9.74M | 9.00% |
| 2021-02-16 | Heights Capital Management, Inc. | - | 0.00% |
| 2021-02-10 | 13-3127734 | 3.95M | 5.76% |
| 2021-02-10 | 26-0385758 | 3.95M | 5.76% |
| 2020-11-19 | Steven D. Rubin | 64239.0 | 0.10% |
| 2020-11-19 | Frost Gamma Investments Trust | 3.66M | 5.30% |
| 2020-11-19 | OPKO Health, Inc. | 2.66M | 3.90% |
| 2020-11-19 | Phillip Frost, M.D. | 3.7M | 5.40% |
| 2020-03-10 | Steven D. Rubin | 54864.0 | 0.10% |
| 2020-03-10 | Phillip Frost, M.D. | 3.69M | 7.80% |
| 2020-03-10 | Frost Gamma Investments Trust | 3.66M | 7.80% |
| 2020-03-10 | OPKO Health, Inc. | 2.66M | 5.60% |
| 2020-03-06 | CVI Investments, Inc. | 3.46M | 7.30% |
| 2020-03-06 | Heights Capital Management, Inc. | 3.46M | 7.30% |
| 2020-03-03 | Wasatch Advisors, Inc. 87-0319391 | - | 0.00% |
| 2020-02-28 | 1,633,035 | 1.63M | 4.20% |
| 2020-02-28 | 10 | 830.54K | 2.10% |
| 2020-02-28 | 1,633,035 | 1.63M | 4.20% |
| 2020-02-28 | 1,633,035 | 1.63M | 4.20% |
| 2020-02-10 | Wasatch Advisors, Inc. 87-0319391 | 1.8M | 5.10% |
| 2019-02-14 | OPKO Health, Inc. | 2.66M | 8.90% |
| 2018-02-02 | OPKO Health, Inc. | 2.24M | 9.10% |
| 2017-05-10 | UMB BANK, n.a. ("UMB") | 3.7M | 7.00% |
| 2015-02-13 | Barry Honig | 3.66M | 2.90% |
| 2014-12-05 | Bracrystal Pharmaceuticals, LLC | 26.8M | 3.80% |
| 2014-12-05 | Roger Kornberg | 15.29M | 2.20% |
| 2014-12-05 | OPKO Health, Inc. | 54.59M | 7.80% |
| 2014-12-05 | Frost Gamma Investments Trust | 100.27M | 14.30% |
| 2014-12-05 | Phillip Frost, M.D. | 100.27M | 14.30% |
| 2014-12-05 | Steven D. Rubin | 639.92K | 0.10% |
| 2014-12-05 | Gary Wilcox | 16.84M | 2.40% |
| 2014-12-05 | Raymond F. Schinazi | 272.96M | 38.90% |
| 2014-12-05 | Sam Lee | 15.29M | 2.20% |
| 2014-08-21 | Phillip Frost, M.D. | 100.27M | 47.80% |
| 2014-08-21 | Frost Gamma Investments Trust | 100.27M | 47.80% |
| 2014-02-14 | GRQ Consultants, Inc. Roth 401k Plan | 1.45M | 1.22% |
| 2014-02-14 | Barry Honig | 5.97M | 4.99% |
| 2013-09-12 | Barry and Renee Honig Charitable Foundation, Inc | 1.43M | 2.04% |
| 2013-09-12 | Barry Honig | 5.54M | 7.91% |
COCP Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.98 | 11.29M | $11.05M | $7.02M | $1.5M | $5.53M |
| 2024-12-31 | $2.02 | 10.17M | $20.55M | $9.86M | $1.81M | $12.5M |
| 2023-12-31 | $1.72 | 9.65M | $16.6M | $26.35M | $1.85M | -$7.9M |
| 2022-12-31 | $1.95 | 8.14M | $15.88M | $37.14M | $297K | -$20.97M |
| 2021-12-31 | $7.80 | 7.69M | $59.97M | $58.7M | $534K | $1.8M |
| 2020-12-31 | $16.32 | 4.8M | $78.27M | $33.01M | $596K | $45.86M |
| 2019-12-31 | $6.00 | 3.05M | $18.32M | $7.42M | $817K | $11.72M |
| 2018-12-31 | $43.20 | 2.33M | $100.83M | $2.72M | $331K | $98.44M |
| 2017-12-31 | $72.00 | 2.01M | $144.76M | $748K | $1.01M | $145.01M |
| 2016-12-31 | $140.40 | 1.96M | $275.43M | $3.64M | -$ | $271.79M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1.01 | 13.79M | $13.92M | $4.68M | $1.42M | $10.66M |
| 2025-12-31 | $0.98 | 11.29M | $11.05M | $7.02M | $1.5M | $5.53M |
| 2025-09-30 | $1.25 | 10.99M | $13.74M | $7.73M | $1.58M | $7.59M |
| 2025-06-30 | $1.49 | 10.17M | $15.16M | $4.77M | $1.66M | $12.05M |
| 2025-03-31 | $1.42 | 10.17M | $14.45M | $6.92M | $1.73M | $9.26M |
| 2024-12-31 | $2.02 | 10.17M | $20.55M | $9.86M | $1.81M | $12.5M |
| 2024-09-30 | $1.76 | 10.17M | $17.91M | $13.02M | $1.88M | $6.76M |
| 2024-06-30 | $2.40 | 10.17M | $24.42M | $18.14M | $1.78M | $8.05M |
| 2024-03-31 | $1.50 | 10.17M | $15.26M | $21.84M | $1.82M | -$4.76M |
| 2023-12-31 | $1.72 | 10.17M | $17.5M | $26.35M | $1.85M | -$7M |
| 2023-09-30 | $1.87 | 10.15M | $18.99M | $29.74M | $118K | -$10.63M |
| 2023-06-30 | $2.39 | 10.06M | $24.06M | $32.49M | $176K | -$8.26M |